Anectine (Sandoz Inc)


Welcome to the PulseAid listing for the Anectine drug offered from Sandoz Inc. This Depolarizing Neuromuscular Blocker [EPC],Neuromuscular Depolarizing Blockade [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sandoz Inc
NON-PROPRIETARY NAME: Succinylcholine Chloride
SUBSTANCE NAME: SUCCINYLCHOLINE CHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Depolarizing Neuromuscular Blocker [EPC],Neuromuscular Depolarizing Blockade [PE]
ROUTE: INTRAMUSCULAR; INTRAVENOUS; PARENTERAL
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1952-08-20
END MARKETING DATE: 0000-00-00


Anectine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAnectine from Sandoz Inc
LABELER NAME: Sandoz Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/mL)
START MARKETING DATE: 1952-08-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0781-3009_086a7742-5f8c-4127-a488-56a1cd245331
PRODUCT NDC: 0781-3009
APPLICATION NUMBER: NDA008453

Other SUCCINYLCHOLINE CHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cantrell Drug CompanySuccinylcholine Chloride
Hospira, Inc.Quelicin
Sandoz IncAnectine